IPO - Samsara BioCapital, L.P.

Form Type: CORRESP

Filing Date: 2024-12-11

Corporate Action: Ipo

Type: Update

Accession Number: 000110465924127650

Filing Summary: Samsara BioCapital, L.P., along with Samsara BioCapital GP, LLC and Srinivas Akkaraju, is responding to a comment from the SEC regarding the late filing of Schedule 13D. The comment, dated December 3, 2024, addresses the failure to file the Schedule 13D within the required five business days after acquiring beneficial ownership of more than five percent of Alumis Inc.'s equity securities on July 1, 2024. Samsara has explained that this delay was due to an administrative oversight and emphasized that the filing was completed promptly after the oversight was recognized. Additionally, they mentioned that they have since reviewed the rules under Section 13 of the Securities Exchange Act and have reassigned roles to prevent future filing issues related to public securities transactions.